- Tytuł :
- Psychiatric Disorders and Hydroxychloroquine for Coronavirus Disease 2019 (COVID-19): A VigiBase Study.
- Autorzy :
- Źródło :
- Drug safety [Drug Saf] 2020 Dec; Vol. 43 (12), pp. 1315-1322. Date of Electronic Publication: 2020 Oct 19.
- Typ publikacji :
- Journal Article
- MeSH Terms :
-
Antiviral Agents/*adverse effects
COVID-19/*drug therapy
Hallucinations/*chemically induced
Hydroxychloroquine/*adverse effects
Psychoses, Substance-Induced/*etiologySelf -Injurious Behavior /*chemically induced
Suicide/*statistics & numerical data
Adenosine Monophosphate/adverse effects ; Adenosine Monophosphate/analogs & derivatives ; Adult ; Aged ; Aged, 80 and over ; Alanine/adverse effects ; Alanine/analogs & derivatives ; Antibodies, Monoclonal, Humanized/adverse effects ; Databases, Pharmaceutical ; Drug Combinations ; Female ; Hallucinations/epidemiology ; Humans ; Lopinavir/adverse effects ; Male ; Mental Disorders/chemically induced ; Mental Disorders/epidemiology ; Middle Aged ; Psychoses, Substance-Induced/epidemiology ; Ritonavir/adverse effects ;Self -Injurious Behavior /epidemiology ; Suicide, Attempted/statistics & numerical data ; Young Adult - SCR Protocol :
- COVID-19 drug treatment
-
Czasopismo naukowe